View Press Releases
-
SynbiCITE launches new five-year strategy
LONDON, UK - Oct 2, 2018 - SynbiCITE, the UKs national centre for commercialisation of synthetic biology, is pleased to announce the launch of a new five-year strategy underpinned by a new £5M grant from UKRI and other sources
Oct 2, 2018
-
CRF Health, a CRF Bracket Company, Brings Industry Together to Lead Debate with eCOA Forum
PLYMOUTH MEETING, PA - Oct 2, 2018 - CRF Health, a CRF Bracket company, the leading provider of patient-centered eSource technology solutions for the life sciences industry, today unveiled details of its 2018 eCOA Forum
Oct 2, 2018
-
Knockout (KO) Validation
CAMBRIDGE, UNITED KINGDOM - Oct 2, 2018 - Antibodies are widely used in pre-clinical research to study proteins and their functions in biological pathways and diseased states
Oct 2, 2018
-
Protein Dynamic Solutions recipient of NSF SBIR Phase IIB Supplemental award
WAKEFIELD, MA - Oct 1, 2018 - Protein Dynamic Solutions (PDS) was awardeda Small Business Innovation Research (SBIR) Phase IIB grant from the National Science Foundation (NSF) to focus on innovative breakthrough applications and commercialization of ProteinMentorTMplatform technology for pre-clinical candidate selection and to help ensure safety and efficacy of therapeutic proteins
Sep 30, 2018
-
UgenTec to extend its software portfolio with FastTyper, a platform used for high-throughput SNP genotyping by end-point PCR
BOSTON, MA - Sep 28, 2018 - UgenTec today announced a new end-point PCR analysis software called FastTyper. FastTyper uses artificial intelligence (AI) methods to significantly accelerate genotyping analysis workflows and improve data interpretation in applications such as agricultural breeding programs
Sep 28, 2018
-
Symbiosis secures FDA viral vector process approval
NEWCASTLE UPON TYNE, UNITED KINGDOM - Sep 27, 2018 - Stirling, UK – SYMBIOSIS Pharmaceutical Services, a fast-growing specialist sterile manufacturing CDMO, has reported FDA approval for its viral vector manufacturing fill/finish process at its biologics manufacturing facility located in Scotland, UK
Sep 27, 2018
-
Major international FDA-led study confirms CellOPTIQ® High Content Assay as leading in vitro platform to assess cardiotoxicity in new drugs
MOTHERWELL, SCOTLAND - Sep 27, 2018 - Clyde Biosciences, the leader in cardiac cell function assessment, announced today that its proprietary CellOPTIQ® High Content Assay (HCA) outperformed other assay types in the global CiPA myocyte study designed to develop more accurate and comprehensive in vitro cardiac safety evaluation of new drugs
Sep 27, 2018
-
Thermo Fisher Scientific Expands Genome Editing IP Portfolio
CARLSBAD, CA, UNITED STATES - Sep 18, 2018 - Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing intellectual property (IP) portfolio
Sep 26, 2018
-
Qlucore AB announces changes to Board of Directors
GUILDFORD, UNITED KINGDOM - Sep 26, 2018 - Pia Gideon has been appointed Chair, having served on the Board of Qlucore AB since 2009. She was previously the Vice President of Marketing and Communication at Ericsson
Sep 26, 2018
-
Certara Launches BaseCase® Portal™, Enabling Life Sciences Companies to Deliver Therapeutic Decision-making Apps to HCPs at the Point of Care
PRINCETON, NJ, US - Sep 26, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, announced today the launch of its BaseCase Portal cloud-based platform, that allows for the rapid creation of fully-customizable mobile apps that connect live to mathematical models and algorithms, and help HCPs optimize treatment for individual patients
Sep 26, 2018
-
LabKey and Linguamatics Partner to Extract Clinical Insights from Big Data in Healthcare
CAMBRIDGE, N/A, UNITED KINGDOM - Sep 25, 2018 - Linguamatics, the leading natural language processing (NLP) text analytics provider, and LabKey, a provider of bioinformatics data management solutions, today announced an integrated solution designed to streamline the extraction and curation of valuable insights from large volumes of unstructured clinical notes and reports
Sep 25, 2018
-
Quanticate partners with CluePoints™ to offer Data Quality Oversight
LONDON, UNITED KINGDOM - Sep 25, 2018 - Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints to utilize their software to drive the statistical analysis to perform data integrity checks on all types of monitoring and investigator site data as part of its new Data Quality Oversight service that enables centralized statistical monitoring, in response to the amendments to the ICH Good Clinical Practice (GCP) E6(R2) guidelines
Sep 25, 2018
-
BioIVT to Host the 2018 HEPATOPAC® User Group Meeting in Boston
WESTBURY, NY, US - Sep 24, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced that it will be hosting the 2018 HEPATOPAC User Group Meeting (UGM) from 8:30 a
Sep 24, 2018
-
ABclonal Technology Unveils Next-Generation Sequencing Kits For Illumina Sequencing Platforms
BOSTON, MA, UNITED STATES - Sep 13, 2018 - ABclonal Technology, a dynamic and growing provider of biological reagents for life science research, today unveiled its new line of next-generation sequencing library preparation kits (NGS lib prep kits), one of the industrys highest-yielding DNA and RNA library preparation kits
Sep 20, 2018
-
H1 Launches ‘Strategy as a Service’ Offering That Helps Life Sciences Companies Cut Time-to-Market in Half
NEW YORK CITY, NY, US - Sep 20, 2018 - FOR IMMEDIATE RELEASE Media contact:Michelle Faulkner
Sep 20, 2018
+1 617-510-6998
michelle@big-swing
-
Oxford Genetics extends its CRISPR Gene Editing Technology License Agreement from ERS Genomics to support its growth internationally
NEWCASTLE UPON TYNE, UNITED KINGDOM - Sep 20, 2018 - Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, and ERS Genomics have extended their pre-existing non-exclusive, license agreement for the use of CRISPR gene editing technology
Sep 20, 2018
-
Domainex appoints Dr Trevor Perrior as Chief Executive Officer
CAMBRIDGE, UK - Sep 20, 2018 - Domainex Ltd, a privately-owned drug research services company, is pleased to announce the appointment of Dr Trevor Perrior as Chief Executive Officer, effective from 1st October 2018
Sep 20, 2018
-
Novel deep learning drug discovery platform gets £1 million innovation boost
, UK - Sep 19, 2018 - Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project
Sep 19, 2018
-
Rho Recruiting New Team Members at SOCRA Annual Conference
CHAPEL HILL, NC, UNITED STATES - Sep 18, 2018 - WHAT: Rho, a full-service contract research organization (CRO), is hiring for a variety of clinical research positions, including clinical research associates (CRAs) and project managers, and will be looking to meet potential applicants during the upcoming Society of Clinical Research Associates (SOCRA) Annual Conference in New Orleans, Louisiana, September 28-30, 2018
Sep 18, 2018
-
Celebrating 10 Years of Sekisui XenoTech
KANSAS CITY, KS, UNITED STATES - Sep 18, 2018 - 10 years ago Sekisui Chemical Company acquired XenoTech and the future of the groundbreaking, innovative CRO was assured
Sep 18, 2018